BXP — BXP, Inc.

The market is split. On the positive side, Q2 2026 revenue rose 3.1% YoY to $895.7M, FFO of $1.78 beat expectations, occupancy improved to 88.4%, and management raised FY26 FFO guidance to $6.99-$7.05. Analysts are constructive, with a consensus Buy rating and targets around $72-$75. On the negative side, the stock is down over the past month, below its 20-day and 50-day moving averages, and institutional flows are mixed, reflecting persistent office-sector and interest-rate anxiety.

Revenue is stable-to-modestly improving: Q2 2026 revenue of $895.7M rose 3.1% YoY versus Q2 2025's $868.5M, after Q1 2026 grew 0.8%, Q4 2025 grew 2.2%, and Q3 2025 grew 1.4%. GAAP earnings remain very noisy because of depreciation, impairments, and property sales: Q2 2026 net income was $68.6M / $0.43 diluted, down from $89.0M / $0.56 in Q2 2025, while Q3 2025 posted a $121.7M net loss and Q4 2025 produced $248.5M of net income. The better REIT metric, FFO, is improving: Q2 2026 FFO was $1.78, and FY26 guidance was raised to $6.99-$7.05. Free cash flow is lumpy and pressured by development capex: Q2 2026 FCF was positive at $97.3M, but Q1 2026 was negative $131.8M, bringing TTM FCF to roughly $360.8M versus about $700.9M in the prior TTM period. Net: the top line and leasing trends are inflecting modestly positive, but cash flow and GAAP earnings are noisy and not yet in a clean acceleration.

Cheap-to-fair on REIT metrics, but expensive-looking on GAAP EPS. As of 2026-09-13, BXP traded at 34.8x TTM EPS of $1.865 and about 30.5x next-FY EPS of $2.123, but those P/E figures are distorted by depreciation and weak GAAP REIT earnings. On the more relevant metric, the $64.70 price is roughly 9.2x the midpoint of FY26 FFO guidance ($7.02), with a 4.22% dividend yield. P/S is 2.93x versus a 5-year average of 3.9x, and the deterministic valuation context labels the stock cheap versus its own history. I would call it cheap on cash flow and dividends, but the discount is justified by high leverage and office-sector risk.

Do not read BXP through its GAAP P/E of 34.8; the REIT is better valued on FFO. At $64.70, the market is paying only about 9.2x FY26 FFO guidance of $6.99-$7.05, which implies skepticism that occupancy gains and leasing momentum can offset refinancing costs and office demand concerns. If BXP hits FFO guidance and the multiple re-rates to 10x-11x, the stock would be worth roughly $70-$77. If occupancy stalls or refinancing costs rise, FFO estimates could be at risk despite the current cheap multiple.

As of 2026-09-13, BXP was technically weak near-term but not broken longer-term. RSI stood at 39.62, not oversold but clearly soft. The $64.70 price was about 4.31% below its 20-day average (~$67.6), 5.45% below its 50-day average (~$68.4), but 1.92% above its 200-day average (~$63.5). The stock is down 4.42% over one week, 4.78% over one month, and 2.38% over three months, yet up 24.4% over six months. Entry-timing implication: wait for a reclaim of the 50-day average or RSI back above 50; a decisive break below the 200-day would signal the medium-term uptrend has failed.

• Interest-rate sensitivity: BXP carries $14.87B of long-term debt and a debt-to-equity ratio of 3.17, so refinancing costs and Fed policy heavily influence FFO and valuation.
• Office utilization and hybrid work: overall office demand remains structurally pressured, but BXP benefits from the flight-to-quality into premier gateway-market assets.
• Credit availability and cap rates: tighter lending or wider cap rates could pressure asset values and development financing, while easier credit would help the entire REIT sector.
• AI/tech-driven leasing demand: pockets of expansion in tech and life-science markets are supporting leasing, as seen in Q2 2026's 1.8M square feet of executed leases.
• Development and construction costs: BXP's large development pipeline, including 343 Madison Avenue, consumes capital and keeps FCF volatile even when operating cash flow is solid.

• Q3 2026 earnings in late October 2026: investors will watch occupancy above 88.4%, leasing velocity, and whether management maintains or raises FY26 FFO guidance of $6.99-$7.05.
• BofA Securities Global Real Estate Conference in mid-September 2026: management commentary on leasing and asset dispositions could shift sentiment.
• Debt refinancing progress: the $700M senior unsecured notes offering in August 2026 and $1.2B construction loan for 343 Madison Avenue show continued capital access, but future refinancing costs remain a swing factor.
• Interest-rate path: any Fed easing would reduce pressure on BXP's leveraged balance sheet and could drive REIT multiple expansion.
• Asset recycling and development leasing: successful leases or dispositions at premium pricing would validate the high-quality portfolio narrative.

• High leverage and refinancing risk: $14.87B of long-term debt and a 0.944 current ratio leave BXP exposed to higher-for-longer interest rates.
• Structural office demand risk: hybrid work continues to reduce overall office utilization, even as BXP's Class A properties outperform secondary assets.
• Free-cash-flow volatility: TTM FCF fell to roughly $360.8M from about $700.9M a year earlier because of elevated development capex, limiting financial flexibility.
• GAAP earnings quality and dividend coverage: TTM EPS of $1.865 is well below the $2.73 annualized dividend implied by the 4.22% yield, even though FFO covers the dividend more comfortably.
• Tenant credit and concentration: large corporate tenants in gateway markets could downsize or default if the economy weakens, pressuring occupancy and rent spreads.

BXP is a high-quality but heavily levered office REIT trading at a depressed 9.2x FY26 FFO with a 4.22% dividend yield. The leasing and occupancy trends are genuinely improving, and the stock is cheap versus its own history, but the balance sheet and secular office headwinds make it a value-trap candidate rather than a clean buy. I would stay cautious until occupancy/FFO momentum is confirmed alongside refinancing progress or a clearer drop in rates.

Applied a 10.0x multiple to the midpoint of management's FY26 FFO guidance of $7.02. That is a modest premium to the current 9.2x P/FFO to reflect improving occupancy and leasing, but a discount to pre-pandemic office REIT multiples because of BXP's 3.17x debt-to-equity and structural office risk. 10.0 x $7.02 = $70.20.